FKBPL: a marker of good prognosis in breast cancer.

about

RALA-mediated delivery of FKBPL nucleic acid therapeutics

P2860

Q37013400-819E0B97-FD13-4023-A1CE-835D21E32B0A

P2860

FKBPL: a marker of good prognosis in breast cancer.

Item

http://www.wikidata.org/entity/Q35828542

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

FKBPL: a marker of good prognosis in breast cancer.

@ast

FKBPL: a marker of good prognosis in breast cancer.

@en

type

Item

label

FKBPL: a marker of good prognosis in breast cancer.

@ast

FKBPL: a marker of good prognosis in breast cancer.

@en

prefLabel

FKBPL: a marker of good prognosis in breast cancer.

@ast

FKBPL: a marker of good prognosis in breast cancer.

@en

P1476

FKBPL: a marker of good prognosis in breast cancer.

@en

P2093

Ahlam Abdunnabi Ali

http://www.w3.org/2001/XMLSchema#string

Andrea Marshall

http://www.w3.org/2001/XMLSchema#string

Anita Yakkundi

http://www.w3.org/2001/XMLSchema#string

Christopher Byrne

http://www.w3.org/2001/XMLSchema#string

David Cameron

http://www.w3.org/2001/XMLSchema#string

Fiona Furlong

http://www.w3.org/2001/XMLSchema#string

Fiona Lanigan

http://www.w3.org/2001/XMLSchema#string

Hayley D McKeen

http://www.w3.org/2001/XMLSchema#string

Helen O McCarthy

http://www.w3.org/2001/XMLSchema#string

Ian Kunkler

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice

Hsp70 chaperones: cellular functions and molecular mechanism

AKT/PKB signaling: navigating downstream

Prognostic molecular markers in early breast cancer

Gene expression profiling predicts clinical outcome of breast cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells.

Multiple imputation of discrete and continuous data by fully conditional specification.

P304

12209-12223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.18632/ONCOTARGET.3528

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275357548

http://www.w3.org/2001/XMLSchema#string

P698

25906750

http://www.w3.org/2001/XMLSchema#string

P932

4494933

http://www.w3.org/2001/XMLSchema#string

FKBPL: a marker of good prognosis in breast cancer.

about

P2860

P2860

FKBPL: a marker of good prognosis in breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932